Please login to the form below

Not currently logged in
Email:
Password:

PatientView

This page shows the latest PatientView news and features for those working in and with pharma, biotech and healthcare.

Asian patient groups give pharma above average marks for reputation

Asian patient groups give pharma above average marks for reputation

New data from PatientView’s established corporate reputation survey show 49% of patient groups in Asia believe the sector has an ‘excellent’ or ‘good’ corporate reputation. ... PatientView’s 2016 Corporate Reputation of Pharma Companies

Latest news

  • Pharma's reputation on the wane, say patient groups Pharma's reputation on the wane, say patient groups

    The pharma industry's reputation with patient groups has taken a turn for the worse, with the latest PatientView survey showing a decline across a majority of metrics. ... was a peak for the sector since PatientView first started conducting the survey of

  • Call for better patient-focused information in cancer Call for better patient-focused information in cancer

    PatientView survey highlights shortcomings in explaining newer science. Patient information in oncology has failed to keep pace with the latest innovations, according to a new multinational survey of patient and carer ... groups. Commissioned by

  • A new era of collaboration A new era of collaboration

    overall reputation for the last three years in the annual PatientView Survey.

  • The Digital Patient The Digital Patient

    According to patient advocacy group PatientView, while patients and members of the public are embracing health apps, doctors are not yet helping them do so, in part because of the confusion ... Regulations governing health apps are 'opaque and outdated',

  • Celgene: Patient voice often underrepresented in pricing debates Celgene: Patient voice often underrepresented in pricing debates

    Celgene was placed 12th in a survey by PatientView of European patient groups - and came 9th in the US version of the survey.

More from news
Approximately 10 fully matching, plus 12 partially matching documents found.

Latest Intelligence

  • Tracking comms trends: tackling reputational issues head on Tracking comms trends: tackling reputational issues head on

    However, strong, positive reputations can be developed. even in pharma. A recent PatientView survey showed that the reputation of the pharmaceutical industry is on the rise – currently reaching a four-year

  • Stronger together Stronger together

    In doing so he said the company has established a very strong patient-focused strategy and culture, something that's certainly been evident with the firm's ranking in PatientView reports.

  • Taking a strategic approach Taking a strategic approach

    A survey of patient groups by PatientView found patients too think pharma often falls short when it comes to drug pricing.

  • Can patient-centricity work for pharma? Can patient-centricity work for pharma?

    A recent survey by PatientView of 1, 150 patient's groups drawn from 58 countries found 39% of respondents thought pharma had either an 'excellent' or a 'good' corporate reputation last

  • Patients First Patients First

    Given that PatientView’s recent study of how patient groups view pharma saw the industry placed a lowly sixth among the eight healthcare-industry sectors ranked, ahead of only

More from intelligence
Approximately 0 fully matching, plus 5 partially matching documents found.

Latest from PMHub

  • Developing your patient-centric strategy

    Pharma should worry about patients’ views of its corporate reputation,” said Alex Wyke, PatientView’s chief executive. ... Nevertheless, more than a third of respondents surveyed by PatientView felt pharma was doing badly on patient-centricity.

  • PatientView

    PatientView's relationship with patient organizations over the past decade has resulted in it gaining an in-depth understanding of the patient movement. ... PatientView. Telephone:44 (0) 1547 520965. Contact.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cogora

Cogora has been a leader in healthcare publishing for over 30 years and has become one of the leading full-service...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics